Back to Monocytopenia With Susceptibility to Infections

Monocytopenia With Susceptibility to Infections — Clinical Trials

MONDO:00136074 active·2 recruitingLast updated: Mar 19, 2026, 11:04 PM

Trial Landscape

Monocytopenia With Susceptibility to Infections has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure2

Biological Therapy1

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

1 trials are observational or have no phase designation.

Sponsor Types

NIH3Academic/Other1

Trial Locations

United States3 trials

Russia1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 of 4 Trials

Phase 2Recruiting

NCT01861106

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2013Est. completion: Dec 2028Updated: Mar 2026

Phase 2Not Yet Recruiting

NCT04844177

Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia

Sponsor:Federal Research Institute of Pediatric Hematology, Oncology and Immunology

RussiaStarted: Apr 2021Est. completion: Apr 2026Updated: Apr 2021

Last updated over 18 months ago

Phase 2Active, Not Recruiting

NCT05907746

Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Nov 2023Est. completion: Jul 2028Updated: Nov 2025

Stay informed about clinical trials for Monocytopenia With Susceptibility to Infections.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 11:04 PM